Filling the need for trusted information on national health issues…

Private Sector Involvement

  • Your Selections:

Refine Results

date

Tags

Johnson & Johnson Deal May Bring HIV/AIDS Drugs To Developing Countries Faster

Johnson & Johnson’s Tibotec Pharmaceuticals unit on Thursday announced it granted multiple licenses to generic drug manufacturers” to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it’s approved by regulators,” Bloomberg Businessweek reports.

Also In Global Health News: Reproductive Health In Philippines; Microfinance Debt In India; HIV/AIDS In Kenya; Google’s DotOrg

Reproductive Health Bill Is Approved By Philippines House Of Representatives IRIN reports a “hotly debated” bill “that proposes national funding for, and access to, reproductive healthcare services and products,” cleared “a major hurdle on [Monday] after being approved by a committee of the Philippines House of Representatives” (2/1). Biliran Rep. Rogelio…

Drug Companies Collaborate With DNDi Support To Develop Drug For African Sleeping Sickness

Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports (Leslie, 6/28).

Shah Talks About Public-Private Partnerships

A post on “PharmaTech Talk” highlights comments made by USAID Administrator Rajiv Shah at the Partnerships for Global Health Forum, an annual event which is sponsored by BIO and BioVentures for Global Health. “Shah talked about the role of public-private partnerships to improve innovations in science and technology. … Shah admitted that in the past it has been hard for the private sector to engage USAID, but he made a point to say that if the biotech/pharma industry builds a breakthrough product that can save lives, USAID will help to deliver it to the populations that need it most. He said USAID is already working to better engage the private sector as well as academic institutions to make such partnerships easier to navigate, and less bureaucratic” (Drakulich, 6/27).

New NIH Program To Identify Nutritional Status Measures

The NIH in a press release said it will begin work on a “new program to discover, develop and distribute measures of nutritional status.” The Biomarkers of Nutrition for Development (BOND) Program “brings together experts in the field of nutrition to provide advice to researchers, clinicians, program- and policymakers, on the…

EU Countries Should Pool Funding To Create ‘Prize’ For Bringing New Antibiotics To Market, Report Says

“European policy makers were urged Wednesday to find viable financial incentives to get drug companies to discover new antibiotics, because the lack of fresh supplies poses acute dangers to health care and efforts against infectious diseases,” according to a report by the Office of Health Economics and funded by GlaxoSmithKline, Dow Jones/Wall Street Journal reports.

Gilead Becomes First Company To License Drugs To Medicines Patent Pool

“In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool,” the New York Times reports (McNeil, 7/12).

BRICS Health Ministers Agree To Improve Access To Low-Cost Medicines

Health ministers from Brazil, Russia, India, China, and South Africa in Beijing “on Monday vowed to improve access to low-cost and high-quality medicine – and called on developed nations to shoulder responsibility in helping the poor,” Agence France-Presse reports (7/11).

Financial Times Examines Product Development Partnerships Researching ‘Neglected’ Diseases

The Financial Times examines the rise of product development partnerships (PDPs), which are “non-governmental organizations that generate their own funding and build partnerships with universities, businesses, government and patients in low-income countries to develop new drugs, vaccines, prevention techniques and diagnostics for diseases such as tuberculosis, HIV, malaria, cholera and meningitis.”

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.